BENZODIAZEPINES— 510(k) K013143
Substantially EquivalentAbbott Laboratories
FDA 510(k) clearance K013143 for BENZODIAZEPINES, Substantially Equivalent on 2002-03-13. Applicant: Abbott Laboratories. Device class: 2.
Clearance details
- Applicant
- Abbott Laboratories
- Product code
- Code JXM
- Device class
- Class 2
- Regulation
- 21 CFR 862.3170
- Advisory panel
- Clinical Toxicology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Irving, TX, US
Recent devices under product code JXM
view allMore clearances from Abbott Laboratories
view allData sourced from openFDA. This site is unofficial and independent of the FDA.